Lifespan predicting DNA test to go on sale

By Admin
A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America. The blood test will be a...

A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America.

The blood test will be available in over-the-counter settings and will cost $700 (£435) when it first goes on sale in Britain later this year.

The test identifies the length of a person’s telomeres which are bits of DNA at the end of the chromosomes.

READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global,
click here
Many people in the US use the internet for medical advice
Twitter is a vital link to patients
iPad 'spinal surgery recovery tracker' is being trialled

Scientists believe that telomeres indicate the speed at which someone ages and those with shorter telomeres tend to die younger than those with long telomeres.

However, critics are branding it controversial and are saying it will open a ‘Pandora’s box’ in which insurance companies will demand a blood test before offering a policy.

Some scientists are also concerned about how people will react if the test delivers bad news, while others are worried it could be used to market fake ‘elixirs of life’.   

A Madrid-based company Life Length has manufactured the test and in an interview Life Length CEO Steve Matlin said the company does not claim the test can predict length of life, it merely just alerts people to high concentrations of short telomeres.

As yet the test is unable to predict the exact amount of months or years a person has left to live although scientists believe telomere testing will become widespread within the next ten years.

Life Length itself is also predicting the demand for the test will be high once they can bring down the price of the test.

Although Life Length is not the only company offering telomere blood tests, they are the only company to be making them available to the public over-the-counter.  

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI